NRAS and acute myeloid leukemia: Consistent with the notion that the NPmut AML transcriptome is mainly driven by the synergistic activities of mutant p53 and oncogenic NRAS, it showed minimal overlap with the NP-/- AML transcriptome, which is predominantly driven by p53 loss (14) (Figure 3D).